Wells Fargo analyst Elyse Greenspan maintained a Buy rating on Metlife (MET – Research Report) yesterday and set a price target of $85.00. The company’s shares closed yesterday at $72.54.
According to TipRanks, Greenspan is a 5-star analyst with an average return of 8.8% and a 64.06% success rate. Greenspan covers the Financial sector, focusing on stocks such as Allstate, American International Group, and Prudential Financial.
Metlife has an analyst consensus of Strong Buy, with a price target consensus of $85.50, representing a 17.87% upside. In a report released on May 6, Piper Sandler also maintained a Buy rating on the stock with a $82.00 price target.
MET market cap is currently $51.58B and has a P/E ratio of 24.93.
Based on the recent corporate insider activity of 116 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MET in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Metlife (MET) Company Description:
Headquartered in New York, MetLife, Inc. is among the largest global providers of insurance and financial services to individual and institutional customers. It offers life insurance, annuities, employee benefits and asset management services. The company operates through the following segments: U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings.
Read More on MET:
- MetLife (NYSE:MET): This “Strong Buy” S&P 500 Stock is an Attractive Insurance Play
- MetLife price target lowered to $82 from $85 at Piper Sandler
- MetLife Announces Q1 Results and $3 Billion Buyback
- MetLife board approves new $3B share repurchase authorization
- MetLife reports Q1 adjusted EPS $1.83 vs $1.52 last year
